SEOUL, South Korea, April 23, 2026 /PRNewswire/ -- Prestige Biopharma IDC, the innovative drug rese...
Primary endpoint of Overall Response Rate at Week 18 met, demonstrating clinical equivalence in pat...
SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- Prestige Biopharma, a biopharmaceutical company specializi...
* Following approval by the European Commission, Prestige Biopharma's Herceptin biosimilar Tuznue...